CN108210596B - 一种降压中药及其制备降压膏敷贴的方法 - Google Patents
一种降压中药及其制备降压膏敷贴的方法 Download PDFInfo
- Publication number
- CN108210596B CN108210596B CN201810227650.8A CN201810227650A CN108210596B CN 108210596 B CN108210596 B CN 108210596B CN 201810227650 A CN201810227650 A CN 201810227650A CN 108210596 B CN108210596 B CN 108210596B
- Authority
- CN
- China
- Prior art keywords
- parts
- blood pressure
- traditional chinese
- liver
- reducing blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000036772 blood pressure Effects 0.000 title claims abstract description 64
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 230000001603 reducing effect Effects 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 15
- 239000011505 plaster Substances 0.000 title claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 206010020772 Hypertension Diseases 0.000 claims description 30
- 230000003276 anti-hypertensive effect Effects 0.000 claims description 23
- 241000157352 Uncaria Species 0.000 claims description 16
- 241000185686 Apocynum venetum Species 0.000 claims description 15
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 15
- 239000002674 ointment Substances 0.000 claims description 15
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 14
- 241001061264 Astragalus Species 0.000 claims description 12
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 claims description 12
- 241001521901 Tribulus lanuginosus Species 0.000 claims description 12
- 235000006533 astragalus Nutrition 0.000 claims description 12
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 11
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 11
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 11
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 11
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 11
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 11
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 11
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 11
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 11
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 11
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 11
- 241000208688 Eucommia Species 0.000 claims description 11
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 11
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 11
- 244000020518 Carthamus tinctorius Species 0.000 claims description 10
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 10
- 235000011477 liquorice Nutrition 0.000 claims description 10
- 241000112528 Ligusticum striatum Species 0.000 claims description 8
- 240000001341 Reynoutria japonica Species 0.000 claims description 8
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229940126680 traditional chinese medicines Drugs 0.000 claims description 8
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 238000007605 air drying Methods 0.000 claims description 5
- 230000007480 spreading Effects 0.000 claims description 5
- 238000003892 spreading Methods 0.000 claims description 5
- 240000007890 Leonurus cardiaca Species 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 93
- 230000007812 deficiency Effects 0.000 abstract description 28
- 229940079593 drug Drugs 0.000 abstract description 26
- 210000003734 kidney Anatomy 0.000 abstract description 23
- 238000002360 preparation method Methods 0.000 abstract description 11
- 238000001467 acupuncture Methods 0.000 abstract description 7
- 230000001077 hypotensive effect Effects 0.000 abstract description 6
- 230000003014 reinforcing effect Effects 0.000 abstract description 6
- 208000001953 Hypotension Diseases 0.000 abstract description 5
- 208000021822 hypotensive Diseases 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 66
- 239000008280 blood Substances 0.000 description 31
- 210000004369 blood Anatomy 0.000 description 30
- 230000001914 calming effect Effects 0.000 description 21
- 230000000144 pharmacologic effect Effects 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 17
- 230000017531 blood circulation Effects 0.000 description 16
- 230000001737 promoting effect Effects 0.000 description 16
- 208000002173 dizziness Diseases 0.000 description 14
- 238000011282 treatment Methods 0.000 description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 235000019640 taste Nutrition 0.000 description 12
- 206010019233 Headaches Diseases 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 231100000869 headache Toxicity 0.000 description 11
- 241001092040 Crataegus Species 0.000 description 9
- 230000002411 adverse Effects 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000004438 eyesight Effects 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 210000000582 semen Anatomy 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 241000207925 Leonurus Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 230000027939 micturition Effects 0.000 description 7
- 240000007087 Apium graveolens Species 0.000 description 6
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 6
- 235000010591 Appio Nutrition 0.000 description 6
- 241000305491 Gastrodia elata Species 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 208000013403 hyperactivity Diseases 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 238000010926 purge Methods 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 5
- 230000003213 activating effect Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 241000722949 Apocynum Species 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 4
- 208000009205 Tinnitus Diseases 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000019633 pungent taste Nutrition 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 210000000453 second toe Anatomy 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 235000019605 sweet taste sensations Nutrition 0.000 description 4
- 210000000431 third toe Anatomy 0.000 description 4
- 231100000886 tinnitus Toxicity 0.000 description 4
- 241001113925 Buddleja Species 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000003516 pericardium Anatomy 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000008093 supporting effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010000234 Abortion spontaneous Diseases 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 241000123846 Buddleja officinalis Species 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000004531 blood pressure lowering effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 208000015994 miscarriage Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 229940095353 oral granules Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 208000000995 spontaneous abortion Diseases 0.000 description 2
- 238000002636 symptomatic treatment Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000212322 Levisticum officinale Species 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 239000001645 levisticum officinale Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种降压中药及其制备降压膏敷贴的方法,有效成分由如下重量份数的原料组成:沙苑子1.5~2.0份、罗布麻2.8~3.2份、白蒺藜1.2~1.8份、生山楂1.2~1.8份、石决明2.5~3.5份、钩藤1.2~1.8份、杜仲1.2~1.8份、菊花1.2~1.8份、益母草1.8~2.2份、川芎1.0~2.0份、红花1.2~1.8份、夜交藤1.2~1.8份、甘草0.4~0.8份,本发明提供一种降压膏敷贴及其制备方法,能够通过药物的补虚泻实、调和阴阳并通过穴位的刺激与调节作用,实现两者的综合叠加作用,使药效直接达到肾脏,直达病灶,降压效果好,而且携带和使用都较为方便。
Description
技术领域
本发明涉及一种降压药,具体涉及一种降压中药及其制备降压膏敷贴的方法。
背景技术
高血压是一种以动脉血压高于正常范围为主要特征,伴有心脏、血管、脑和肾脏等器官功能性或器质性改变的临床综合征。古代中医典籍中本无“高血压”之记载,但据本病临床表现当属传统医学“眩晕”“头痛”“肝风”等范畴,其中以“眩晕”归属者最为多见。《内经》云:“诸风掉眩,皆属于肝”、“髓海不足,则脑转耳鸣,颈酸眩冒”、“上虚则眩”、“木郁之发……甚则耳鸣眩转”;朱丹溪曰“无痰不作眩”;张景岳云:“无虚不作眩”;《诸病源候论》云:“胸膈饮渍于五脏……亦令目眩头痛”,《千金方》曰:“肝厥头痛,肝火厥逆,上亢头脑也,其痛必至巅顶,以肝之脉于督脉会于巅,故肝厥头痛必多眩晕等”。
高血压多由于七情所伤、饮食失节、内伤虚损等,引起阴阳失衡、气血失和,以风、火、痰、瘀为患。病损的脏器主要在肝、脾、肾。主要病机有肝阳上亢、气血亏虚、肾精不足、痰湿中阻、瘀血阻窍等。因此高血压病理性质多为本虚标实,其中以肝肾阴虚、气血亏虚为本,风、火、痰、瘀为标。
中国专利“一种治疗高血压的药物组合物及其制备方法、制剂与应用”,申请日为:2017.03.16,公告日为:2017.08.17,公开了治疗高血压的药物组合物包括原料重量份的天麻100~300份、菊花50~200份、石决明100~200份、罗布麻50~150份、干地黄40~100份,诸药联合,协同作用,共奏滋肾养肝,平肝熄风之功,有显著的降压作用,用于高血压的治疗。
中国专利“一种治疗高血压病的药物”,申请日为:2017.07.24,公告日为:2017.12.08,公开了一种治疗高血压病的药物属在治疗高血压病过程中使用的药物,采用纯正中药材:生地、白芍、生石决明、生龙骨等十一种纯中药,在治疗高血压,肝肾阴虚,肝阳上亢等方面取得了显著效果,有效率可达99%以上。
中国专利“一种有效治疗高血压的中药制剂”,申请日为:2016.01.21,公告日为:2016.05.25,公开了一种有效治疗高血压的中药制剂,是由以下中药原料制成,酸枣仁、夜交藤、浙贝母、川芎、密蒙花、侧柏叶、玉竹、沙苑子、郁李仁、仙灵脾、龙胆、蔓荆子、藁本、鼠曲草、竹沥、莲须、桑枝、女贞子、蓬莪术、滇常山、南藤、肝风草、茺蔚子、海带根、旱芹、柠条根、枣树皮、头发七、苜蓿;将上述各种中药原料进行合理搭配,本制剂具有补益肝肾、育阴潜阳、活血消痰、利水泻火、清热祛瘀等功效,可以恢复肝肾排毒解毒功能,降低甘油三脂、胆固醇以及血液粘稠度,从根本上清除血滞,恢复血管壁弹性,进而改善血液循环,可以彻底解除头痛、头晕、失眠、心悸、胸闷、易疲劳等症状,最终实现平稳降压、稳压的目的。
通过分析可知现有的治疗高血压的中药大都以补虚为治则通过滋肾养肝、育阴潜阳、健脾益气、平肝熄风达到降压的目的。但是高血压临床上亦常见虚实夹杂之证。
发明内容
针对目前现有高血压临床上常见的虚实夹杂之证,本发明提供一种降压膏敷贴及其制备方法,能够通过药物的补虚泻实、调和阴阳并通过穴位的刺激与调节作用,实现两者的综合叠加作用,使药效直接达到肾脏,直达病灶,降压效果好,而且携带和使用都较为方便。
其解决问题的技术方案是:一种降压中药,有效成分由如下重量份数的原料组成:沙苑子1.5~2.0份、罗布麻2.8~3.2份、白蒺藜1.2~1.8份、生山楂1.2~1.8份、石决明2.5~3.5份、钩藤1.2~1.8份、杜仲1.2~1.8份、菊花1.2~1.8份、益母草1.8~2.2份、川芎1.0~2.0份、红花1.2~1.8份、夜交藤1.2~1.8份、甘草0.4~0.8份。
优选地,一种降压中药,有效成分由如下重量份数的原料组成:沙苑子1.8份、罗布麻3.0份、白蒺藜1.5份、生山楂1.5份、石决明3.0份、钩藤1.5份、杜仲1.5份、菊花1.5份、益母草2.0份、川芎1.5份、红花1.5份、夜交藤1.5份、甘草0.6份。
将上述中药制备降压膏敷贴的方法:
(1)把各种原料按重量份数备齐,风干;
(2)加工粉碎;
(3)采用白醋将步骤(2)处理后的原料调匀成膏状。并摊于敷贴上制成膏贴。其中白醋味酸,属肝,不仅可收敛肝阴,又可引诸药入经,用其调制可加强其散瘀止痛、理气活血之效。
优选地,步骤(2)中采用超微粉碎技术粉碎。使其为颗粒粒径在 10um 以下的粉末。
上述降压中药按照临床要求制成所需的膏剂。
一种降压膏敷贴的使用方法:
(1)选取足底部前部凹陷处第二、三趾趾缝纹头端与足跟连线的前三分之一处的涌泉穴;
(2)碘伏消毒穴位部的皮肤;
(3)将沙罗降压膏均匀填满敷贴;
(4)将敷贴贴敷于双侧涌泉穴,每日一次,每次6至8小时。
高血压病理性质多为本虚标实,其中以肝肾阴虚、气血亏虚为本,风、火、痰、瘀为标,临床上以虚证为多见,亦常见虚实夹杂之证。治疗当以补虚泻实为治则。本发明提供降压膏敷贴,将沙苑子、罗布麻、白蒺藜、生山楂、石决明、钩藤、杜仲、菊花等十多味中药,按照合理有效的重量份数调成药膏。以沙苑子和罗布麻共用为君药,一温一凉,一补一泻,通过补虚泻实,调和阴阳而降压。以白蒺藜、石决明、钩藤和菊花四者寒温并用为臣药,具有平肝泻热息风之效,可助君药降压之力。通过生山楂、杜仲、益母草、川芎、红花和夜交藤六者合用为佐药,补养肝肾、活血散瘀、清热泻火,针对高血压病因中之虚、瘀、火等而用之。甘草为使药,通过调和诸药,又补脾益气、祛痰止咳,针对高血压病理因素中之痰。纵观全方,上述十多味中药寒温并用,补泻兼施,标本兼顾,共奏降压之效。
将本发明提供降压膏敷贴并选用足底双侧涌泉穴敷贴,涌泉穴为足少阴肾经之井穴,具有开窍、泻热、降逆的功效,选用涌泉穴可使药效直接达到肾脏,肾把药物快速的供给全身各个器官,可使血液里的毒素和细菌排出,软化和扩张血管,增加血液流量,使血压快速下降。因此该降压膏敷贴不但实现穴位的刺激与调节作用,还加强了降压膏吸收后的治疗作用,最终实现两者的综合叠加作用。使药效直接达到肾脏,直达病灶,达到以补虚泻实的目的,而且起效快。
同时该降压膏敷贴直接外用,无需内服,相比内服的方式,对患者身体的副作用小,尤其是对肝部不但无损伤,还有补肝养肝效果。而且该该降压膏敷贴携带方便,不需要长时间煎煮使其使用也较为方便。
具体实施方式
以下结合实施例对本发明的内容作进一步详细说明:
实施例1:一种降压中药,有效成分由如下重量份数的原料组成:沙苑子1.8份、罗布麻3.0份、白蒺藜1.5份、生山楂1.5份、石决明3.0份、钩藤1.5份、杜仲1.5份、菊花1.5份、益母草2.0份、川芎1.5份、红花1.5份、夜交藤1.5份、甘草0.6份。
制备降压膏敷贴的方法:把各种原料按重量份数备齐,风干,然后采用超微粉碎技术粉碎加工粉碎,使其为颗粒粒径在 10 um 以下的粉末,再采用白醋将处理后的原料调匀成膏状,并摊于敷贴上制成膏贴。
实施例2:一种降压中药,有效成分由如下重量份数的原料组成:沙苑子1.5份、罗布麻2.8份、白蒺藜1.2份、生山楂1.2份、石决明2.5份、钩藤1.2份、杜仲1.2份、菊花1.2份、益母草1.8份、川芎1.0份、红花1.2份、夜交藤1.2份、甘草0.4份。
制备降压膏敷贴的方法:把各种原料按重量份数备齐,风干,然后采用超微粉碎技术粉碎加工粉碎,使其为颗粒粒径在 10 um 以下的粉末,再采用白醋将处理后的原料调匀成膏状。并摊于敷贴上制成膏贴。
实施例3:一种降压中药,有效成分由如下重量份数的原料组成:沙苑子2.0份、罗布麻3.2份、白蒺藜1.8份、生山楂1.8份、石决明3.5份、钩藤1.8份、杜仲1.8份、菊花1.8份、益母草2.2份、川芎2.0份、红花1.8份、夜交藤1.8份、甘草0.8份。
制备降压膏敷贴的方法:把各种原料按重量份数备齐,风干,然后采用超微粉碎技术粉碎加工粉碎,使其为颗粒粒径在 10 um 以下的粉末,再采用白醋将处理后的原料调匀成膏状。并摊于敷贴上制成膏贴。
本发明所用药物:
沙苑子:味甘,性温;归肝、肾经;具有补肾助阳、固精缩尿、养肝明目之功效。
现代药理学研究显示:沙苑子能增强机体的非特异性和特异性免疫功能;沙苑子中的总黄酮对肾血管性高血压大鼠有明显降压作用。
罗布麻:味甘、苦,性凉;归肝经;具有平肝安神、清热利水之功效。
现代药理学研究表明,罗布麻叶有降压、减慢心率、减弱心肌收缩力的作用,且其浸膏有镇静、抗惊厥作用,并有较强的利尿、降低血脂等作用。
白蒺藜:味辛、苦,性微温;归肝经;具有平肝解郁、活血祛风、明目、止痒之功效。
现代药理学研究表明,白蒺藜对麻醉动物有降压、利尿作用。
石决明:味咸、性微寒;归肝经;具有平肝潜阳、清肝明目之功效。
现代药理学研究表明,石决明具有降血压、镇静、降脂、保肝等作用。
钩藤:味甘、性凉;归肝、心包经;具有息风定惊、清热平肝之功效。
现代药理学研究表明,钩藤有降血压、镇静、抗惊厥、抗血栓、降血脂、扩血管等作用。
菊花:味甘、苦;性微寒;归肺、肝经;具有疏散风热、平抑肝阳、清肝明目、清热解毒之功效。
现代药理学研究表明,菊花制剂有扩张冠状动脉、增加冠脉血流量、提高心肌耗氧量的作用。并具有降压、镇静、解热、抗炎、缩短凝血时间的作用。
生山楂:味酸、甘,性微温;归脾、胃、肝经;具有消食健胃、行气散瘀、化浊降脂之功效。
现代药理学研究表明,山楂提取物能扩张冠状动脉,增加冠脉血流量,保护缺血缺氧的心肌,并可强心、降血压、降血脂及抗心律失常。
杜仲:味甘、性温;归肝、肾经;具有补肝肾、强筋骨、安胎之功效。
现代药理学研究表明,杜仲能促进骨髓基质细胞增殖,利于骨折愈合;水煎剂及醇提物均具有降压作用。
益母草:味苦、辛;性微寒;归肝、心包、膀胱经;具有活血调经、利尿消肿、清热解毒之功效。
现代药理学研究表明,益母草粗提物能扩张血管,有短暂降压作用,且其生物碱有明显的利尿作用。
川芎:味辛、性温;归肝、胆、心包经;具有活血行气、祛风止痛之功效。
现代药理学研究表明,川芎嗪能扩张冠脉血管,增加冠脉血流量;扩张脑血管,改善微循环;预防血栓形成。川芎总生物碱、川芎嗪能降低外周血管阻力,有显著而持久的降压作用;能显著增加肾血流量,延缓慢性肾损害。
红花:味辛,性温;归心、肝经;具有活血通经、散瘀止痛之功效。
现代药理学研究表明,红花黄色素能扩张血管、降低血压;扩张冠状动脉、改善心肌缺血;对抗心律失常等。
夜交藤:味甘、性平;归心、肝经;具有养血安神、祛风通络之功效。
现代药理学研究表明,首乌藤有抗慢性炎症、抗菌、镇静催眠作用,能促进免疫功能。
甘草:味甘、性平;归心、肺、脾、胃经;具有补脾益气、清热解毒、祛痰止咳、缓急止痛、调和诸药之功效。
现代药理学研究表明,甘草有抗利尿、降血脂、保肝与肾上腺皮质激素样作用。
高血压病理性质多为本虚标实,其中以肝肾阴虚、气血亏虚为本,风、火、痰、瘀为标。本发明从导致高血压的理论出发,通过寒性与温性并用,补泻兼施,标本兼顾,共奏降压之效;同时降压膏敷贴并选用足底双侧涌泉穴敷贴,不但实现穴位的刺激与调节作用,还加强了沙罗降压膏吸收后的治疗作用,最终实现两者的综合叠加作用,有很好的临床价值和社会价值。
本发明从众多的中药中选取上述药物制成降压膏贴,并按照临床要求制成所需的膏剂,通过长期的临床及大量的资料研究,取得很好的效果。
疗效观察
近期疗效达 81.3%左右,远期疗效也有近 70%以上。在用降压膏敷贴药膏三日后,具有明显的降压效果,七日后血压基本恢复,其他不良症状消失。
肝阳偏盛型的总为 85.2%,肝肾阴虚型的总为 79.4%,阴阳两虚型总为76.2%。
“近期疗效”是指:
(1)在 3~7 天内,测试血压明显降低;
(2)在 3~7 天内,症状缓解或消失:如头痛、性情急躁、失眠、口干苦、面红目赤、头胀、肝风、乏力、心悸、气短心慌、健忘等;
(3)患者精神好转,能参加一定的体力劳动或娱乐活动。
(4)生活质量提高,睡眠改善,饮食和起居正常,能进行一般的体力劳动、或娱乐活动。
“远期疗效”是:停药一年后,血压恢复至平稳且不再复发,并能从事一定的体力劳动。
将实施例1所提供的配方取药,按常规方法制成汤剂及口服颗粒。用药三天,观察近期疗效,汤剂为46%左右,口服颗粒为52.5%左右。相比实施1提供的配方制成膏剂的近期疗效,汤剂和口服颗粒起效较慢。
将实施例1所提供的配方取药:选取足底部前部凹陷处第二、三趾趾缝纹头端与足跟连线的前三分之一处的涌泉穴,用碘伏消毒穴位部的皮肤,然后将沙罗降压膏均匀填满敷贴,之后将敷贴贴敷于双侧涌泉穴,每日一次,每次6至8小时。使用过程中若出现红疹,则及时对症处理后,隔天贴敷。用药三天,观察近期疗效达88%。而将实施例1所提供的配方取药敷贴足底部其他穴位,用药三天,观察近期疗效为54.6%,相比选取足底部前部凹陷处第二、三趾趾缝纹头端与足跟连线的前三分之一处的涌泉穴,起效较慢。
对比例1:该对比例为将实施例1中的钩藤用天麻代替,其余均相同。
对比例2:该对比例为将实施例1中的沙苑子用桑螵蛸代替,其余均相同。
对比例3:该对比例为将实施例1中的罗布麻用旱芹代替,其余均相同。
对比例4:该对比例为将实施例1中的菊花用密蒙花代替,其余均相同。
对比例1钩藤用天麻代替,虽然钩藤与天麻密蒙花药理药效上有许多的共性,例如,钩藤的息风定惊、清热平肝功效与天麻的息风止痉,平肝潜阳,祛风通络功效相近,但是用天麻代替钩藤治疗效果明显变差,近期疗效为45.1%左右,治疗起效慢,而且治疗周期相对较长,远期疗效仅为38.6%左右。
对比例2沙苑子用桑螵蛸代替,沙苑子与桑螵蛸药理药效上有许多的共性,例如沙苑子的补肾助阳、固精缩尿、养肝明目功效与桑螵蛸的补肾助阳的功效相近。但是配方中用桑螵蛸代替沙苑子治疗效果明显变差,近期疗效为56.8%左右,远期疗效仅为42.1%左右,同时还伴随有咳嗽、水肿等不良症状。
对比例3罗布麻用旱芹代替,虽然罗布麻与旱芹药理药效上有许多的共性,罗布麻的平肝安神、清热利水功效与旱芹的平肝降压的功效相近。但是配方中用旱芹代替罗布麻治疗效果明显变差,近期疗效为51.9%左右,远期疗效仅为39.1%左右,而且伴随有浮躁、乏力等不良症状。
对比例4菊花用密蒙花代替,虽然密蒙花药理药效上有许多的共性。例如菊花的疏散风热、平抑肝阳、清肝明目、清热解毒功效与密蒙花的祛风,凉血,润肝,明目的功效相近。但是配方中用旱芹代替罗布麻治疗效果明显变差,近期疗效为49.9%左右,远期疗效仅为37.5%左右,而且伴随有嗜睡、腹泻等不良症状。
临床药效试验
本发明以实施例1~3及对比例1~4所提供的降压中药的原料配方制成的降压膏敷贴,做临床疗效总结如下:
一、一般性资料:本发明提供的降压膏敷贴应用于临床观察病例70例,平均分为七组,每组10人,其中每组男5例,女5例,年龄均在40~80岁之间。其中,第一组使用实施例1提供的原料配方制成的降压膏敷贴;第二组使用实施例2提供的原料配方制成的降压膏敷贴;第三组使用实施例3提供的原料配方制成的降压膏敷贴;第四组使用对比例1提供的原料配方制成的降压膏敷贴;第五组使用对比例2提供的原料配方制成的降压膏敷贴;第六组使用对比例3提供的原料配方制成的降压膏敷贴,第七组使用对比例4提供的原料配方制成的降压膏敷贴。
二、诊断标准:
1、头痛、目眩、头胀、肝风、乏力、心悸、失眠多梦、气短心慌;
2、诊断表现收缩压和舒张压较高。
三、用法用量:本药膏选取足底部前部凹陷处第二、三趾趾缝纹头端与足跟连线的前三分之一处的涌泉穴,用碘伏消毒穴位部的皮肤,然后将沙罗降压膏均匀填满敷贴,之后将敷贴贴敷于双侧涌泉穴,每日一次,每次6至8小时。使用过程中若出现红疹,则及时对症处理后,隔天贴敷。
四、疗效标准:
1、治愈:高血压症状全部消失,血压检查正常;
2、好转:高血压症状基本消失,血压明显降低;
3、未愈;高血压症状无明显改善。
五、治疗效果:该临床观察病例中,每组患者使用相应原料配方制成的降压膏敷贴药膏七日后,治疗效果如表1所示:
| 治疗标准 | 第一组 | 第二组 | 第三组 | 第四组 | 第五组 | 第六组 | 第七组 |
| 治愈 | 9 | 8 | 8 | 5 | 3 | 3 | 2 |
| 好转 | 1 | 1 | 2 | 2 | 3 | 4 | 4 |
| 未愈 | 0 | 1 | 0 | 3 | 4 | 3 | 4 |
表1 治疗效果
首先,有表1中第一~七组疗效效果可知,第一~七组提供的降压膏敷贴具有较快的降压效果。同时在该临床观察病例中,第一~三组患者在使用实施例1~3原料配方制成的降压膏敷贴药膏三日后,具有明显的降压效果,七日后血压基本恢复,其他不良症状消失。停药一年后,血压恢复至平稳且不再复发的占 70%以上,疗效较好。
其次,由表1可知在相同条件下实施例1提供的降压膏敷贴,临床效果对比疗效显著优于对比例1~4提供的降压膏敷贴。发现, 本发明的配方是一个有机整体且缺一不可,是从寒温并用,补泻兼施及各药彼此协调的角度考虑的。不是单纯药效类似就可以等效替代的,而是从各药彼此协调的角度考虑的。可能药效相似的药物很多,但是能够达到协调性好的药物却不多见。从传统中药君臣佐使理论而言:本方沙苑子味甘,性温,具有补肾助阳、固精缩尿、养肝明目之功效;罗布麻叶味甘、苦,性凉,具有平肝安神、清热利水之功效。二者同用,一温一凉,一补一泻,共用为君,可补虚泻实,调和阴阳而降压。
白蒺藜味辛、苦,性微温,具有平肝解郁、活血祛风、明目、止痒之功效。石决明味咸、性微寒;具有平肝潜阳、清肝明目之功效。钩藤味甘、性凉;具有息风定惊、清热平肝之功效。菊花味甘、苦;性微寒;具有疏散风热、平抑肝阳、清肝明目、清热解毒之功效。此四者寒温并用,具有平肝泻热息风之效,可助君药降压之力,共为臣药。
生山楂味酸、甘,性微温;具有消食健胃、行气散瘀、化浊降脂之功效。杜仲味甘、性温;可补肝肾、强筋骨、安胎之功效。益母草味苦、辛;性微寒;可活血调经、利尿消肿、清热解毒之功效。川芎味辛、性温;具有活血行气、祛风止痛之功效。红花味辛,性温;具有活血通经、散瘀止痛之功效。夜交藤味甘、性平;具有养血安神、祛风通络之功效。此六者合用,可补养肝肾、活血散瘀、清热泻火,针对高血压病因中之虚、瘀、火等而用之,共为佐药。甘草为使,既可调和诸药,又可补脾益气、祛痰止咳,针对高血压病理因素中之痰,一药而多用。纵观全方,各药不是单一发挥其既要药效,而是寒温并用,补泻兼施,标本兼顾,共奏降压之效。
基于以上方药的药理和功效,结合穴位敷贴透穴吸收的特点,及治疗效果可知,实施例1所提供的降压中药制备的膏敷贴的效果最好。
六、典型病例:
病例 1 :刘女士,59 岁,患高血压 20 多年,用药前常头痛而胀,耳鸣如蝉,心烦口干,用药前血压测量值为110/180mmHg,按照本发明实施例1所提供的降压膏敷贴,贴于涌泉穴,用药三日后恢复正常饮食,头痛、耳鸣等症状明显减轻,坚持用药一星期以后,血压85/130mmHg,其他不良症状消失,治愈。现停药近一年,血压一直正常。
病例 2 :陶某,男,48 岁,5 年前出现间断性头晕、头痛、伴随视力模糊,呕吐等症状,诊断为高血压,测量值为 125/175mmHg,长时间服用卡托普利、硝苯地平等降压药,造成肠胃肝脾肾功能紊乱,不能下地劳动和料理家务。按照本发明实施例2所提供的降压膏敷贴,贴于涌泉穴,用药三日后,坚持用药七日后,血压恢复正常 84/129mmHg,不适症状消失,治愈。现停药近一年,血压一直正常。
病例3:王女士,75岁,患高血压 20 多年,用药前有心慌、气短、失眠健忘、四肢麻木、恶心、食不知味、严重时卧床不起等症状,用药前血压测量值为120/180mmHg,本发明实施例3所提供的降压膏敷贴,用药三日后恢复正常饮食,坚持用药一星期以后,血压明显下降,其他不良症状消失,好转。现停药近一年,血压一直血压一直较为稳定。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (5)
1.一种降压中药,其特征在于,有效成分由如下重量份数的原料组成:沙苑子1.5~2.0份、罗布麻2.8~3.2份、白蒺藜1.2~1.8份、生山楂1.2~1.8份、石决明2.5~3.5份、钩藤1.2~1.8份、杜仲1.2~1.8份、菊花1.2~1.8份、益母草1.8~2.2份、川芎1.0~2.0份、红花1.2~1.8份、夜交藤1.2~1.8份、甘草0.4~0.8份。
2.根据权利要求1所述的一种降压中药,其特征在于,有效成分由如下重量份数的原料组成:沙苑子1.8份、罗布麻3.0份、白蒺藜1.5份、生山楂1.5份、石决明3.0份、钩藤1.5份、杜仲1.5份、菊花1.5份、益母草2.0份、川芎1.5份、红花1.5份、夜交藤1.5份、甘草0.6份。
3.权利要求1或2所述的降压中药制备降压膏敷贴的方法,其特征在于,步骤为:(1)把各种原料按重量份数备齐,风干;(2)加工粉碎;(3)采用白醋将步骤(2)处理后的原料调匀成膏状,并摊于敷贴上制成膏贴。
4.根据权利要求3所述制备降压膏敷贴的方法,其特征在于,步骤(2)中采用超微粉碎技术粉碎。
5.根据权利要求1或2所述的一种降压中药,其特征在于:按照临床要求制成所需的膏剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810227650.8A CN108210596B (zh) | 2018-03-20 | 2018-03-20 | 一种降压中药及其制备降压膏敷贴的方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810227650.8A CN108210596B (zh) | 2018-03-20 | 2018-03-20 | 一种降压中药及其制备降压膏敷贴的方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108210596A CN108210596A (zh) | 2018-06-29 |
| CN108210596B true CN108210596B (zh) | 2021-07-16 |
Family
ID=62658731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810227650.8A Active CN108210596B (zh) | 2018-03-20 | 2018-03-20 | 一种降压中药及其制备降压膏敷贴的方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108210596B (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107661421A (zh) * | 2016-07-27 | 2018-02-06 | 徐培森 | 一种治疗高血压的组方 |
-
2018
- 2018-03-20 CN CN201810227650.8A patent/CN108210596B/zh active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107661421A (zh) * | 2016-07-27 | 2018-02-06 | 徐培森 | 一种治疗高血压的组方 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108210596A (zh) | 2018-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078520B (zh) | 一种治疗神经性头痛的中药制剂及其制备方法 | |
| CN101810685B (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
| CN103169928B (zh) | 治疗痛经的外用中药组合物及其制备方法和应用 | |
| CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN103316146B (zh) | 一种麻醉用中药制剂 | |
| CN107737288B (zh) | 一种治疗过敏性哮喘的中药组合物及其制备方法 | |
| WO2025097959A1 (zh) | 一种治疗尿失禁的中药组合物、制备方法及应用 | |
| CN105561002A (zh) | 一种艾叶保健足浴粉及其制备方法 | |
| CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
| CN108210596B (zh) | 一种降压中药及其制备降压膏敷贴的方法 | |
| CN105343660A (zh) | 一种治疗周围性眩晕的中药制剂及其制造方法 | |
| CN104435225A (zh) | 一种治疗高血压的中药及其胶囊的制备方法 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN107260978B (zh) | 一种治疗高血压的中药组合物及其制备方法和用途 | |
| CN105343688A (zh) | 一种治疗心肌梗塞的药物组合物及其应用 | |
| CN113679781B (zh) | 一种治疗快速性心律失常的中药组合物及其制备方法和应用 | |
| CN104825650A (zh) | 一种安神健脑口服液 | |
| CN104367896B (zh) | 一种治疗气虚血瘀型中风的药物组合物及其制备方法 | |
| CN105456972A (zh) | 一种龟鹿益肾中药组合物及其制备方法 | |
| CN115054641B (zh) | 一种刮痧药油及其制备方法 | |
| CN102824468A (zh) | 一种治疗高血压病的中药及制备方法 | |
| CN111407868B (zh) | 改善大脑认知功能的中药丸剂 | |
| CN106389821A (zh) | 一种治疗输血溶血反应的中药制剂及其制备方法 | |
| CN118252886A (zh) | 一种具有改善皮肤瘙痒的外用草本精华液 | |
| CN119679897A (zh) | 一种辅助治疗阳虚水泛型水肿的穴位贴敷中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |